(Q34743030)

4 August 2017

title

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions (English)

1 reference

4 August 2017

0 references

1 reference

surgical intervention

1 reference

1

Christopher G Goetz

1 reference

4 August 2017

12

Sue Leurgans

1 reference

4 August 2017

4

Charles H Adler

1 reference

4 August 2017

7

Robert A Hauser

1 reference

4 August 2017

5

Stanley Fahn

1 reference

4 August 2017

Parkinson Study Group

11

object named as

Parkinson Study Group

1 reference

4 August 2017

9

Ira Shoulson

1 reference

4 August 2017

Joanne Wuu

2

1 reference

4 August 2017

Michael P McDermott

3

1 reference

4 August 2017

Curt R Freed

6

1 reference

4 August 2017

Warren C Olanow

8

1 reference

4 August 2017

P K Tandon

10

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

23

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

690-699

1 reference

Scientific and ethical issues in the use of placebo controls in clinical trials

4 August 2017

cites work

1 reference

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

21 January 2018

1 reference

Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease

21 January 2018

1 reference

Longitudinal data analysis for discrete and continuous outcomes

21 January 2018

1 reference

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study

21 January 2018

1 reference

A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study

21 January 2018

1 reference

Levodopa and the progression of Parkinson's disease

21 January 2018

1 reference

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

Neurobiological mechanisms of the placebo effect.

21 January 2018

1 reference

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 January 2018

1 reference

Patient compliance with paper and electronic diaries

21 January 2018

1 reference

Core assessment program for intracerebral transplantations (CAPIT)

21 January 2018

1 reference

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

21 January 2018

1 reference

Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus

21 January 2018

1 reference

The placebo effect in neurological disorders.

21 January 2018

1 reference

Overt versus covert treatment for pain, anxiety, and Parkinson's disease

21 January 2018

1 reference

Placebo and opioid analgesia-- imaging a shared neuronal network

21 January 2018

1 reference

The functional neuroanatomy of the placebo effect

21 January 2018

1 reference

Placebo-induced changes in FMRI in the anticipation and experience of pain

21 January 2018

1 reference

Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers

21 January 2018

1 reference

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

21 January 2018

1 reference

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.21894

1 reference

4 August 2017

1 reference